BIGT vs. GENG ETF Comparison
Comparison of L&G Pharma Breakthrough UCITS ETF (BIGT) to UBS (IRL) ETF PLC UBS (IRL) ETF GL GEN EQ HDG GPB ACC (GENG)
BIGT
L&G Pharma Breakthrough UCITS ETF
BIGT Description
The objective of the fund is to provide exposure to a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. The Index selects stocks that meet certain size and liquidity requirements using a two-fold approach that is primarily based on the trend in the valuation of a companyâs orphan drug portfolio and its overall revenue forecasts.
Grade (RS Rating)
Last Trade
£740.35
Average Daily Volume
2,916
Number of Holdings
*
8
* may have additional holdings in another (foreign) market
GENG
UBS (IRL) ETF PLC UBS (IRL) ETF GL GEN EQ HDG GPB ACC
GENG Description
The UBS (Irl) ETF plc – Global Gender Equality UCITS ETF sub-fund is an exchange traded fund incorporated in Ireland. The objective of this share class is to deliver the performance of the Solactive Equileap Global Gender Equality 100 Leaders Net Total Return Index and allow intraday trading.Grade (RS Rating)
Last Trade
£2,011.00
Average Daily Volume
112
Number of Holdings
*
53
* may have additional holdings in another (foreign) market
Performance
| Period | BIGT | GENG |
|---|---|---|
| 30 Days | -3.46% | 0.53% |
| 60 Days | -5.47% | 1.33% |
| 90 Days | -7.26% | 3.67% |
| 12 Months | -21.07% | 10.73% |
BIGT Underweight 51 Positions Relative to GENG
| Symbol | Grade | Weight | |
|---|---|---|---|
| 0FQI | A | -1.29% | |
| 0R01 | A | -1.27% | |
| 0M29 | A | -1.26% | |
| 0R2F | A | -1.24% | |
| 0HOY | A | -1.2% | |
| 0I58 | F | -1.18% | |
| 0IFA | C | -1.16% | |
| 0J5I | C | -1.15% | |
| 0Q16 | A | -1.14% | |
| 0Q1S | D | -1.14% | |
| 0IIF | C | -1.1% | |
| 0KU1 | A | -1.06% | |
| 0GT1 | B | -1.05% | |
| ADM | A | -1.04% | |
| 0R2Z | D | -1.04% | |
| 0M6S | A | -1.03% | |
| BRFI | C | -1.02% | |
| DSM | F | -1.01% | |
| 0KFX | C | -1.0% | |
| 0R3T | D | -1.0% | |
| 0HJF | F | -1.0% | |
| 0K0X | C | -0.99% | |
| 0KYY | D | -0.99% | |
| 0NVV | A | -0.99% | |
| 0R1X | B | -0.98% | |
| 0IIW | F | -0.98% | |
| 0NOF | A | -0.96% | |
| AZN | B | -0.95% | |
| ITV | B | -0.95% | |
| NG | C | -0.95% | |
| 0Y0Y | F | -0.95% | |
| 0HJI | C | -0.94% | |
| 0OJC | D | -0.94% | |
| WPP | B | -0.94% | |
| 0NZM | C | -0.94% | |
| 0A6B | B | -0.92% | |
| SSE | C | -0.92% | |
| 0OQV | D | -0.9% | |
| XSG | F | -0.89% | |
| ULVR | F | -0.88% | |
| 0NRE | C | -0.88% | |
| 0R0G | C | -0.87% | |
| TATE | C | -0.83% | |
| VOD | D | -0.82% | |
| STAN | B | -0.82% | |
| 0HEW | D | -0.77% | |
| 0O7D | F | -0.75% | |
| 0J8Z | F | -0.75% | |
| 0LSZ | F | -0.75% | |
| 0J3F | D | -0.71% | |
| 0A4S | F | -0.64% |
BIGT: Top Represented Industries & Keywords
Industries:
Drug Manufacturers - Major
Keywords:
Biopharmaceutical
Drugs
Medical Specialties
Organ Systems
Rare Diseases
Alzheimer's Disease
Duchenne Muscular Dystrophy
Follicular Lymphoma
Gene Therapy
Immunosuppressants
Medicine
Monoclonal Antibodies
Multiple Sclerosis
Muscular Dystrophy
Neuroscience
Orphan Drugs
Plaque Psoriasis
Smallpox
Vaccination
Vaccines
GENG: Top Represented Industries & Keywords
Compare ETFs
